These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 31863336)

  • 1. Liver Buds and Liver Organoids: New Tools for Liver Development, Disease and Medical Application.
    Zeng F; Zhang Y; Han X; Weng J; Gao Y
    Stem Cell Rev Rep; 2019 Dec; 15(6):774-784. PubMed ID: 31863336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse engineering liver buds through self-driven condensation and organization towards medical application.
    Shinozawa T; Yoshikawa HY; Takebe T
    Dev Biol; 2016 Dec; 420(2):221-229. PubMed ID: 27364470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organoids of liver diseases: From bench to bedside.
    Wu LJ; Chen ZY; Wang Y; Zhao JG; Xie XZ; Chen G
    World J Gastroenterol; 2019 Apr; 25(16):1913-1927. PubMed ID: 31086460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases.
    Fiorotto R; Amenduni M; Mariotti V; Fabris L; Spirli C; Strazzabosco M
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):920-928. PubMed ID: 30264693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine.
    Olgasi C; Cucci A; Follenzi A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver organoid as a 3D in vitro model for drug validation and toxicity assessment.
    Brooks A; Liang X; Zhang Y; Zhao CX; Roberts MS; Wang H; Zhang L; Crawford DHG
    Pharmacol Res; 2021 Jul; 169():105608. PubMed ID: 33852961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease Modeling in Stem Cell-Derived 3D Organoid Systems.
    Dutta D; Heo I; Clevers H
    Trends Mol Med; 2017 May; 23(5):393-410. PubMed ID: 28341301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in organoid development and applications in disease modeling.
    Rauth S; Karmakar S; Batra SK; Ponnusamy MP
    Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188527. PubMed ID: 33640383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer.
    Chen Y; Liu Y; Chen S; Zhang L; Rao J; Lu X; Ma Y
    Front Immunol; 2023; 14():1180184. PubMed ID: 37334366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commercialization of Organoids.
    Choudhury D; Ashok A; Naing MW
    Trends Mol Med; 2020 Mar; 26(3):245-249. PubMed ID: 31982341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organogenesis in a dish: modeling development and disease using organoid technologies.
    Lancaster MA; Knoblich JA
    Science; 2014 Jul; 345(6194):1247125. PubMed ID: 25035496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled liver organoids recapitulate hepatobiliary organogenesis in vitro.
    Vyas D; Baptista PM; Brovold M; Moran E; Gaston B; Booth C; Samuel M; Atala A; Soker S
    Hepatology; 2018 Feb; 67(2):750-761. PubMed ID: 28834615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays.
    Brandenberg N; Hoehnel S; Kuttler F; Homicsko K; Ceroni C; Ringel T; Gjorevski N; Schwank G; Coukos G; Turcatti G; Lutolf MP
    Nat Biomed Eng; 2020 Sep; 4(9):863-874. PubMed ID: 32514094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What gastroenterologists and hepatologists should know about organoids in 2019.
    Günther C; Brevini T; Sampaziotis F; Neurath MF
    Dig Liver Dis; 2019 Jun; 51(6):753-760. PubMed ID: 30948332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organoids: Current Implications and Pharmaceutical Applications in Liver Diseases.
    Zhu M; Huang Y; Bian S; Song Q; Zhang J; Zheng W; Cheng C
    Curr Mol Pharmacol; 2021 Oct; 14(4):498-508. PubMed ID: 33334301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro organogenesis from pluripotent stem cells.
    Li Y; Xu C; Ma T
    Organogenesis; 2014; 10(2):159-63. PubMed ID: 24762764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural organoids for disease phenotyping, drug screening and developmental biology studies.
    Hartley BJ; Brennand KJ
    Neurochem Int; 2017 Jun; 106():85-93. PubMed ID: 27744003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver organoids: from basic research to therapeutic applications.
    Prior N; Inacio P; Huch M
    Gut; 2019 Dec; 68(12):2228-2237. PubMed ID: 31300517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell-derived organoids and their application for medical research and patient treatment.
    Bartfeld S; Clevers H
    J Mol Med (Berl); 2017 Jul; 95(7):729-738. PubMed ID: 28391362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.